Genome British Columbia
Steven Zicherman, CFA, serves as a member of the Board of Directors at Genome British Columbia since January 2024, contributing to the advancement of genomics research and innovation. With a tenure at Odlum Brown Limited that began in May 2014, Zicherman holds the positions of Director, Equity Analyst, and Portfolio Manager, providing clients with value-based investment advice. Previous board experience includes Arts Umbrella, and Zicherman has held various investment roles at HSBC Global Asset Management, RBC Technology Ventures, and Credit Suisse. Academically, Zicherman earned an MBA from Dalhousie University and a BA in Statistics from Western University.
This person is not in the org chart
This person is not in any teams
Genome British Columbia
Genome British Columbia leads genomics innovation on Canada’s West Coast and facilitates the integration of genomics into society. A recognized catalyst for government and industry, Genome BC invests in research, entrepreneurship and commercialization in life sciences to address challenges in key sectors such as health, forestry, fisheries, aquaculture, agri-food, energy, mining and environment. Genome BC partners with many national and international public and private funding organizations to drive BC’s bioeconomy. www.genomebc.ca In addition to research, entrepreneurship and commercialization programs, Genome BC is committed to fostering an understanding and appreciation of the life sciences among teachers, students and the general public. In the last five years Genome BC has engaged over 271,578 BC students in 191 schools and 81 communities through its outreach activities. www.genomebc.ca